Por: CBS News Politics August 05, 2023
The Food and Drug Administration announced Friday it has approved the first oral treatment for postpartum depression. The drug, called zuranolone, is a once-a-day pill that will be branded as Zurzuvae by drugmakers Sage Therapeutics and Biogen. Zuranolone is approved for use in adults for the , an episode of major depression that can begin after childbirth or the later stages of pregnancy, which affects an estimated 15% of women in the weeks or... + full article
ABC News USA Life July 27, 2023
A pill for led to meaningful improvements in depression symptoms, according to a late-stage published Wednesday in The American Journal of Psychiatry.The pill, zuranolone, is not yet approved, but the Food and Drug Administration is expected to make its approval decision by Aug... + más
Mom goes viral sharing reality of her postpartum body | ABC News
Kylie Jenner reveals she had postpartum depression twice | ABC News
ABC7 USA World July 27, 2023
led to meaningful improvements in depression symptoms, according to a late-stage published Wednesday in The American Journal of Psychiatry.The pill, zuranolone, is not yet approved, but the Food and Drug Administration is expected to make its approval decision by Aug 5.In the... + más
ABC News USA Life February 23, 2023
Kylie Jenner recently opened up about her experience with a personal issue that many women face, but rarely share: .In an interview with Vanity Fair published Wednesday, the mother of two spoke about having postpartum depression not once, but twice, after both of her... + más
Meet Kylie McDevitt Kelce, the wife of Eagles center Jason Kelce | New York Post
Kylie Jenner slams claim she posted pics of her kids to 'cover up for Balenciaga': 'Always something to say' | Fox News
New York Post USA Life February 08, 2023
A first-of-its-kind pill for postpartum depression could be available to women in the US by August. The medication, called Zuranolone, is an antidepressant that is only taken for two weeks and is in a class of drugs that target GABA receptors — which control signaling in the... + más
I wanted to put a knife into my baby: Moms on their postpartum psychosis | Newsweek
FDA sets a decision date for Sage’s postpartum depression pill | The Boston Globe
ABC News USA Life February 08, 2023
A first-of-its-kind pill designed to help treat is one step closer to being available to new mothers.The drug, called Zuranolone, is now being reviewed by the U.S. Food and Drug Administration, which has until Aug. 5, 2023, to decide whether or not to approve the drug based on... + más
First pill for postpartum depression could be approved by August: FDA | New York Post
The Boston Globe USA Business February 06, 2023
An experimental drug that in a clinical trial helped some women quickly recover from postpartum depression could be approved by federal regulators by Aug. 6. The medicine, developed by Sage Therapeutics, is poised to become the first pill for the condition, which afflicts as... + más
A pill for postpartum depression is on the horizon | The Boston Globe
The Boston Globe USA Business February 05, 2023
Stephanie Hathaway knows the agony of postpartum depression all too well, having been tormented by intrusive suicidal thoughts after each of her two daughters were born. Both bouts were excruciating, but the second, in 2017, was unremitting.Hathaway took an antidepressant that... + más
About iurex | Privacy Policy | Disclaimer |